URBN
48
-6
DFS
64
2
RRC
52
-6
HPE
44
-2
XYL
35
-2
BA
47
2
LEN
50
-2
ADBE
47
-9
HSY
31
-6
RHI
57
-6
COST
57
-6
HUM
41
-4
NEE
54
7
MDLZ
32
-4
DHI
44
-3
NEM
40
3
TXN
43
-5
WMT
56
-4
SO
57
6
PG
50
2
URBN
48
-6
DFS
64
2
RRC
52
-6
HPE
44
-2
XYL
35
-2
BA
47
2
LEN
50
-2
ADBE
47
-9
HSY
31
-6
RHI
57
-6
COST
57
-6
HUM
41
-4
NEE
54
7
MDLZ
32
-4
DHI
44
-3
NEM
40
3
TXN
43
-5
WMT
56
-4
SO
57
6
PG
50
2
Financhill
Back

ProPhase Labs Vs. Repligen Industry Stock Comparison

Sell
19

PRPH
ProPhase Labs

Last Price:
0.74
Seasonality Move:
18.16%
Sell
30

RGEN
Repligen

Last Price:
124.90
Seasonality Move:
7.3%
Sell
19
ProPhase Labs (PRPH) is a Sell

Is ProPhase Labs a Buy, Sell or Hold?

  • The current ProPhase Labs [PRPH] share price is $0.75. The Score for PRPH is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • PRPH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Repligen (RGEN) is a Sell

Is Repligen a Buy, Sell or Hold?

  • The current Repligen [RGEN] share price is $124.73. The Score for RGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRPH Stock Price Chart

What is ProPhase Labs's stock price today?

  • The ProPhase Labs share price today is $0.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing slight buying pressure.

RGEN Stock Price Chart

What is Repligen's stock price today?

  • The Repligen share price today is $124.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing selling pressure, which indicates risk of future bearish movement.

PRPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.44 Sell
Relative Strength Index (14 RSI): 16.44 Sell
Chaikin Money Flow: 50708 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.22 - 2.56) Sell
Bollinger Bands (100): (1.91 - 3.27) Sell

RGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.46 Sell
Relative Strength Index (14 RSI): 36.22 Sell
Chaikin Money Flow: -1285419 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (134.94 - 146.38) Sell
Bollinger Bands (100): (130 - 153.64) Sell

PRPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.99 Sell
20-day SMA: 1.77 Sell
50-day SMA: 2.17 Sell
200-day SMA: 3.91 Sell
8-day EMA: 1.03 Sell
20-day EMA: 1.54 Sell
50-day EMA: 2.07 Sell
200-day EMA: 3.52 Sell

RGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 142.02 Sell
20-day SMA: 140.23 Sell
50-day SMA: 141.19 Sell
200-day SMA: 157.58 Sell
8-day EMA: 139.7 Sell
20-day EMA: 140.54 Sell
50-day EMA: 141.71 Sell
200-day EMA: 151.3 Sell

ProPhase Labs Earnings Growth & PRPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.43 per share.

Repligen Earnings Growth & RGEN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.

ProPhase Labs Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Repligen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):